Home
About Stabilitech
The need for stabilisation
Proprietary Technology
Investors, News and Media
Careers
The Stabilisation Company
Site map
Primary links
Home
About Stabilitech
Board of Directors
Management
Scientific Advisory Board
The need for stabilisation
Biopharmaceuticals and Other Biological Products
Vaccines
Proprietary Technology
Potential Advantages of Stabilitechs Technology
Investors, News and Media
Careers
Secondary links
About Stabilitech
Proprietary Technology
Contact Us
Press Releases
About Stabilitech
Proprietary Technology
Contact Us
Press Releases
Download a recent company presentation
Listen to radio interview: TechNation, Jan 2011
News
Programme to overcome major hurdle in stabilisation of cells starts 1 February
31/01/2012
Stabilitech Ltd's Regenerative Medicine Technology programme (“RegenMed”) to address the major problem of the stabilisation of cells.
Stabilitech raises £2.2 million to drive expansion of business and maximise potential of innovative technology platform
12/05/2011
The funding will be used to progress the commercialision of its cutting edge proprietary thermal stabilisation technology platform
Stabilitech appoints new Commercial Director
05/02/2011
Stabilitech announced the appointment of Donna Hackett as Commercial Director
Last Updated:
Tuesday, 31st January, 2012
